StockNews.AI
FNA
StockNews.AI
147 days

PARAGON 28 STOCKHOLDER NOTICE: Kaskela Law LLC Announces Investigation of Paragon 28, Inc. (NYSE: FNA) Proposed Stockholder Buyout and Encourages Investors to Contact the Firm for Additional Information

1. Paragon 28, Inc. is under investigation regarding its buyout by Zimmer Biomet. 2. Proposed buyout price is $13.00 per share, plus potential $1.00 contingent value. 3. Analysts previously set price targets above $15.00 per share for Paragon. 4. Investigation focuses on fairness and potential breaches of fiduciary duty. 5. Paragon shares will be delisted after the buyout, affecting shareholder value.

M&A
+0.08%Current Return
VS
-1.18%S&P 500
$13.0103/25 11:38 AM EDTEvent Start
$13.0203/26 06:16 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Bearish?

Concerns over fairness of the buyout price may undermine investor confidence. Historical cases, like Sprint's acquisition, showed stock price adjustments post-investigations.

How important is it?

The investigation reflects significant shareholder dissatisfaction, impacting FNA's perceived value.

Why Short Term?

Immediate legal investigations can swiftly affect market sentiment. Similar scenarios have historically prompted rapid sell-off reactions.

Related Companies

ZBHSPRACMD
PHILADELPHIA, March 25, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of Paragon 28, Inc. (“Paragon”) (NYSE: FNA) shareholders. Click here for additional information: https://kaskelalaw.com/case/paragon-28/ On January 28, 2025, Paragon announced that it had agreed to be acquired by Zimmer Biomet Holdings, Inc. (“Zimmer”) at an upfront price of $13.00 per share in cash plus a non-tradable contingent value right (CVR) worth up to an additional $1.00 in cash upon the achievement of certain milestones. Following the closing of the proposed transaction, Paragon’s shareholders will be cashed out of their investment position and the company’s shares will no longer be publicly traded. The investigation seeks to determine whether Paragon’s shareholders will be receiving sufficient monetary consideration for their shares, and whether the company’s officers and/or directors breached their fiduciary duties or violated the securities laws in agreeing to the buyout price with Zimmer. Notably, at the time the proposed transaction was announced, several stock analysts were maintaining price targets for the company’s shares at or above $15.00 per share. Paragon shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750 for additional information about this investigation and their legal rights and options. Alternatively, investors may submit their information to the firm by clicking on the following link (or if necessary, by copying and pasting the link into your browser): https://kaskelalaw.com/case/paragon-28/ Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis, which means that the firm’s clients never pay any out-of-pocket costs for legal representation. For additional information about Kaskela Law LLC, including the firm’s recent notable recoveries for investors, please visit www.kaskelalaw.com. CONTACT:KASKELA LAW LLC D. Seamus Kaskela, Esq.(skaskela@kaskelalaw.com)Adrienne Bell, Esq.(abell@kaskelalaw.com)18 Campus Blvd., Suite 100Newtown Square, PA 19073(484) 229 – 0750www.kaskelalaw.comThis notice may constitute attorney advertising in certain jurisdictions.

Related News